Brief: Elite Pharmaceuticals Receives Approval From FDA On May 16, For A Generic Version Of Methotrexate Sodium 2.5 Mg Tablets
20/05/2024 23:48
May 20 (Reuters) - Elite Pharmaceuticals Inc ELTP.PK :
* ELITE PHARMACEUTICALS INC - RECEIVED APPROVAL FROM FDA ON
MAY
16, FOR A GENERIC VERSION OF METHOTREXATE SODIUM
(“METHOTREXATE”) 2.5 MG TABLETS
Source text for Eikon: ID:n0001493152-24-020707
Further company coverage: ELTP.PK
((reuters.briefs@thomsonreuters.com;))
Recent news on Elite Pharmaceuticals
See all newsBrief: Elite Pharmaceuticals Receives Approval From FDA On May 16, For A Generic Version Of Methotrexate Sodium 2.5 Mg Tablets
Brief: Lannett Enters Into Distribution Agreement For Dantrolene Capsules
Brief: Lannett Enters Into Distribution Agreement For Generic Adderall
Brief: Elite Pharmaceuticals Gets FDA Approval For Generic Version Of Allergan's Pain Treatment Tablets
Brief: Elite Pharmaceuticals Files ANDA For Codeine And Acetaminophen Combo